LifeTech Scientific Corp. | Mutual Funds

Mutual Funds that own LifeTech Scientific Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Wellington Mgmt. Port (Dublin) Plc - Global Health Care Eq.
43,532,971
1%
4,102,971
0.49%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
30,738,000
0.71%
-420,000
0.01%
07/31/2018
Vanguard Total International Stock Index Fund
29,180,903
0.67%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
26,210,000
0.6%
0
0.01%
09/05/2018
Desjardins Emerging Markets Opportunities Fund
24,570,000
0.56%
0
1.31%
04/30/2018
DFA Emerging Markets Small Cap Series
16,038,000
0.37%
0
0.05%
01/31/2018
13,136,164
0.3%
2,960,164
1.36%
12/31/2017
12,934,000
0.3%
0
0.8%
09/06/2018
DFA Emerging Markets Core Equity Portfolio
8,484,000
0.2%
-2,266,000
0.01%
04/30/2018
United Global Healthcare Fund
7,491,990
0.17%
1,221,130
0.45%
12/31/2017

About LifeTech Scientific

View Profile
Address
Cybio Electronic Building
Shenzhen Guangdong 518057
China
Employees -
Website http://www.lifetechmed.com
Updated 07/08/2019
LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. It operates its business through the following segments: Congenital Heart Diseases, Peripheral Vascular Diseases and Surgical Vascular Repair. It offers Occluders, Stent graft system, Delivery system, Vena cava filter, Vascular plug, Sizing ballon, Dilator and Snare system.